Health Canada
- Status: approved
Upfront therapy with oral spironolactone (Upfront therapy with oral spironolactone) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Hasselt University is the originator. The local marketing authorisation holder may differ — check the official source linked above.